- Goals of Treatment, Indication, and Treatment for Chronic Hepatits C
-
Paik SW
- KMID: 1767541
- Korean J Gastroenterol.
- 2008 Jun;51(6):368-371.
Hepatitis C virus (HCV) is a major cause of chronic hepatitis and hepatic fibrosis worldwide. Up to 85% of individuals infected with HCV develop chronic infection, which can progress to... -
- CITED
-
- Close
- SHARE
-
- Close
- Well differentiated hepatocellular carcinoma: ddmPathological diagnosis of needle biopsied liver tissue
-
Seok JY, Park YN
- KMID: 1776820
- Korean J Hepatol.
- 2009 Mar;15(1):96-100.
- doi: 10.3350/kjhep.2009.15.1.96
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Association of Chronic Hepatitis C Virus Infection and Diabetes Mellitus in Korean Patients
-
Ryu JK, Lee SB, Hong SJ, Lee S
- KMID: 759530
- Korean J Intern Med.
- 2001 Mar;16(1):18-23.
BACKGROUND: It has been suggested that chronic hepatitis C virus (HCV) infection is associated with diabetes. The aim of this study was to establish a potential relationship between chronic HCV... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C
-
Shin MK, Kim TH, Ju K, Ha CY, Min HJ, Jung WT, Lee OJ
- KMID: 1374966
- Korean J Hepatol.
- 2009 Sep;15(3):370-374.
- doi: 10.3350/kjhep.2009.15.3.370
Combination therapy of pegylated interferon alpha and ribavirin has been associated with various adverse effects, but sudden-onset hearing loss is uncommon. We report a 60-year-old male patient who developed sudden-onset... -
- CITED
-
- Close
- SHARE
-
- Close
- Metastatic hepatocellular carcinoma presenting as facial nerve palsy and facial pain
-
Yang JI, Kang JM, Byun HJ, Chung GE, Yim JY, Park MJ, Lee JH, Yoon JH, Lee HS
- KMID: 1792611
- Korean J Hepatol.
- 2011 Dec;17(4):319-322.
- doi: 10.3350/kjhep.2011.17.4.319
Facial nerve palsy due to temporal bone metastasis of hepatocellular carcinoma (HCC) has rarely been reported. We experienced a rare case of temporal bone metastasis of HCC that initially presented... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation
-
Kim BK, Kwon SY, Ko SY, Choe WH, Lee CH, Han HS, Chang SH
- KMID: 1073304
- Korean J Hepatol.
- 2008 Dec;14(4):519-524.
- doi: 10.3350/kjhep.2008.14.4.519
Fibrosing cholestatic hepatitis (FCH) is the most devastating manifestation of recurrent hepatitis C in transplant recipients with hepatitis C virus (HCV), possibly leading to death or retransplantation. Although FCH was... -
- CITED
-
- Close
- SHARE
-
- Close
- Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin
-
Lee TH, Lee KO, Kim YS, Kim SM, Huh KC, Choi YW, Kang YW
- KMID: 1792063
- Korean J Intern Med.
- 2014 May;29(3):370-374.
- doi: 10.3904/kjim.2014.29.3.370
Various adverse events have been reported during combination therapy with pegylated (PEG)-interferon-alpha and ribavirin, although opportunistic infections, especially cryptococcal meningitis, are very rare. A 61-year-old woman complained of headaches and... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: A comparative study
-
Kim JI, Kim SH, Lee BS, Lee HY, Lee TH, Kang YW, Lee HI, Kim AN, Nam SW, Park BC, Chae HB, Kim SB, Song IH, Park JY, Kim HS
- KMID: 1073301
- Korean J Hepatol.
- 2008 Dec;14(4):493-502.
- doi: 10.3350/kjhep.2008.14.4.493
BACKGROUNDS/AIMS: Peginterferon alpha-2a or -2b is the standard treatment regimen in chronic hepatitis C. However, there have been few comparative studies of the efficacies of these two types of... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of and risk factors for thyroid dysfunction during peginterferon alpha and ribavirin treatment in patients with chronic hepatitis C
-
Hwang Y, Kim W, Kwon SY, Yu HM, Kim JH, Choe WH
- KMID: 2381583
- Korean J Intern Med.
- 2015 Nov;30(6):792-800.
- doi: 10.3904/kjim.2015.30.6.792
BACKGROUND/AIMS: Thyroid dysfunction (TD) is more likely to occur in patients with chronic hepatitis C (CHC) and is particularly associated with interferon (IFN) treatment. The purpose of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Revision and update on clinical practice guideline for liver cirrhosis
-
Suk KT, Baik SK, Yoon JH, Cheong JY, Paik YH, Lee CH, Kim YS, Lee JW, Kim DJ, Cho SW, Hwang SG, Sohn JH, Kim MY, Kim YB, Kim JG, Cho YK, Choi MS, Kim HJ, Lee HW, Kim SU, Kim JK, Choi JY, Jun DW, Tak WY, Lee BS, Jang BK, Chung WJ, Kim HS, Jang JY, Jeong SW, Kim SG, Kwon OS, Jung YK, Choe WH, Lee JS, Kim IH, Shim JJ, Cheon GJ, Bae SH, Seo YS, Choi DH, Jang SJ
- KMID: 1372646
- Korean J Hepatol.
- 2012 Mar;18(1):1-21.
- doi: 10.3350/kjhep.2012.18.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
